Exhibit
10.1


 


This
INVESTMENT AND FUNDING AGREEMENT (“Agreement”), made as of December 2, 2020, by and between:


 


	 	●	YOUR
    SICAV-SIF (hereafter referred to as the “Fund”) a company incorporated under the laws of Luxembourg,
    currently having its registered office located at 106 Route D`Arlon, L-8210 Mamer, Luxembourg, acting solely in relation to
    the Sub-Fund YOUR SICAV-SIF – FORTUNA GLOBAL GROWTH (hereafter referred to as the “Investor”); and
    
	 	 	 
	 	●	ARGENTUM
    47, INC. (hereafter referred to as the “Company”), a corporation organized under the laws of the State
    of Nevada, United States of America, whose principal place of business is currently 34 St. Augustine’s Gate, Hedon,
    HU12 8EX, United Kingdom.
	 	 	 
	 	 	Jointly,
    hereafter referred to as the “Parties”.


 


RECITALS:


 


	 	a)	The
    Fund is based in Luxembourg and regulated by the CSSF in Luxembourg.
	 	b)	The
    Company is a corporate consulting business and financial services company that desires to obtain funding from the Investor,
    on the terms and conditions set forth below.
	 	c)	The
    Company ́s common shares are currently quoted on the U.S. NASDAQ OTC Markets under the trading symbol ARGQ.
	 	d)	The
    Company’s International Securities Identification Number (ISIN) is US 04017D1046.
	 	e)	Any
    reference to the Fund in this Agreement refers exclusively to the Fund acting on behalf of the Investor.


 


NOW,
THEREFORE, in consideration of the mutual covenants contained herein, the parties hereto agree as follows:


 


	 	1.	Investment
    Commitment. 


 


The
Fund agrees to commit and invest into the Company a maximum of $5,000,000 (Five Million U.S. Dollars) in various tranches with
a minimum total investment commitment of $3,000,000 (Three Million U.S. Dollars).


 


The
Fund agrees that the first tranche of investment shall be a minimum of $500,000 (Five Hundred Thousand U.S. Dollars) and this
first tranche of investment shall be transferred to the Company within 10 working days from the date that is formally requested.


 


The
Fund agrees that all subsequent tranches of funds invested in the Company shall also be transferred to the Company within 10 working
days from the date that these subsequent tranches are formally requested by the Company.


 


The
Company agrees that it will ensure a minimum of 60 calendar days between each request for a tranche of investment.


 


	 	2.	Conversion
    into Equity and Maturity Dates.


 


The
Parties agree that each tranche of funds invested into the Company (“Tranche”) shall be evidenced by a “Convertible
Note” in the amount of such Tranche, bearing a coupon at the rate of 8% (Eight per cent) per annum, that shall accrue semi-annually.


 


The
Parties agree that each “Convertible Note” shall become due and payable (convertible) on the 547th calendar
day (18 months and 1 day) following receipt of each Tranche (“Maturity Date”).


 




    	 



     


    




 


The
Parties agree that on each Maturity Date, the outstanding Convertible Notes shall be automatically converted into shares of Company’s
common stock at a conversion price equal to closing price of Company’s common stock on the NASDAQ OTC Bulletin Board two
working days prior to each conversion.


 


Attached
hereto as Exhibit “A” and incorporated herein by reference is a copy of the form of “Convertible Note”
that will be issued hereunder. In the event of any discrepancy between this Investment Agreement and the “Convertible Notes”,
the terms and conditions of the Convertible Notes shall control.


 


	 	3.	Use
    of Proceeds. 


 


The
Company warrants that it will use the proceeds of each Tranche of Investment for inorganic growth via the acquisition of one or
various Independent Financial Advisory firms with funds under management, legal and audit fees plus any other acquisition related
fees and finally, general working capital purposes. The Fund agrees with such use of proceeds.


 


	 	4.	Amendment;
    Breach and Waiver. 


 


This
Agreement may not be amended or modified in any manner, except by an instrument in writing duly executed by both parties hereto.
The failure of either party hereto to enforce at any time any of the provisions of this Agreement shall in no way be construed
to constitute a waiver of any such provision or any other provision, or of the right of such party thereafter to enforce each
and every such provision or other provision in the event of a subsequent breach of this Agreement.


 


	 	5.	Agreement
    Binding Upon Successors. 


 


This
Agreement shall inure to the benefit of, and shall be binding upon, the parties hereto, their successors and assigns.


 


	 	6.	Choice
    of Law and Forum. 


 


This
Agreement shall be governed by and construed in accordance with the Laws of Luxembourg, exclusive of its choice-of-law principles.
Each party hereby submits to the jurisdiction of the civil courts of Luxembourg. In any action or proceeding arising out of or
relating to this Agreement or any of the Convertible Notes issued pursuant hereto, each party hereto hereby irrevocably waives
the defences of improper venue or inconvenient forum for the maintenance of any such action or proceeding to the fullest extent
permitted by law.


 


	 	7.	Counterparts.
    


 


This
Agreement may be executed in multiple counterparts, each of which shall be deemed an original, but both of which together shall
constitute one and the same instrument.


 


	 	8.	Section
    Headings. 


 


The
Section headings contained in this Agreement are for reference purposes only and shall not affect in anyway the meaning or interpretation
of this Agreement.


 


	 	9.	Public
    Disclosure. 


 


A
copy of this Agreement will be formally filed, with the U.S. Securities and Exchange Commission (SEC), via a Form 8-K within three
working days from the date that this Agreement is fully executed.


 


	 	10.	Subsequent
    Funding Agreements.


 


The
Parties agree that the Fund will be offered the option to enter into a new investment agreement for a further $5,000,000 (Five
Million U.S. Dollars) once the entire $5,000,000 (Five Million U.S. Dollars) related to this current Agreement has been fully
disbursed by the Investor to the Company.


 




    	 



     


    

 


The
Parties also agree that if the Fund agrees to enter into such subsequent agreement, the terms and conditions of this subsequent
agreement shall be the same as this current agreement.


 


	 	11.	Entire
    Agreement. 


 


This
Agreement constitutes the entire agreement between the parties hereto with respect to the subject matter hereof, and there are
no agreements, covenants, undertakings, restrictions, warranties, promises or representations between the parties with respect
to the subject matter hereof other than those set forth herein.


 


IN
WITNESS WHEREOF, the parties hereto have executed this Agreement as of the day first written above.


 


	On
    behalf of the Investor:	 	On
    behalf of the Company:
	 	 	 
	YOUR
    SICAV-SIF	 	ARGENTUM
    47, INC.
	 	 	 
	/s/
    Herve Coussement	 	/s/
    Peter Smith
	Mr.
    Herve Coussement - Director	 	Mr.
    Peter Smith - Director
	 	 	 
	December
    2, 2020	 	December
    3, 2020
	 	 	 
	YOUR
    SICAV-SIF	 	ARGENTUM
    47, INC.
	 	 	 
	/s/
    Philippe Maclot	 	/s/
    Enzo Taddei
	Mr.
    Philippe Maclot - Director	 	Mr.
    Enzo Taddei - Director
	 	 	 
	December
    2, 2020 	 	December
    3, 2020


 


Exhibit
“A” to Exhibit 10.1 of Form 8-K


 


	Note
    No.:	________
	 	 
	Principal
    Amount:	U.S.$
    __________________
	 	 
	Issue
    Date: 	________________
    ___, 202_
	 	 
	Maturity
    Date: 	________________
    ___, 202_
	 	 
	Purchase
    Price: 	Par


 




    	 



     


    

 


CONVERTIBLE
NOTE


 


FOR
INVESTMENT TRANCHE RECEIVED, ARGENTUM 47, INC., a corporation organized under the laws of the State of Nevada, United
States of America (the “Company”), hereby promises, YOUR SICAV-SIF – FORTUNA GLOBAL GROWTH (the
“Holder”), to convert into shares of the Company ́s common stock, the sum of U.S.$_________________
with any interest as set forth herein, on _________________ __, 202_ (“Maturity Date”), and to accrue interest
semi-annually on the unpaid principal balance invested hereof at the rate of Eight per cent (8%) (“Interest Rate”)
per annum from the date hereof (“Issue Date”) until the same becomes due and convertible on the maturity date.


 


This
Note may not be prepaid in whole or in part except as otherwise explicitly set forth herein. Interest shall commence accruing
on the date that the Note is fully funded and shall be computed based on a 365-day year and the actual number of days elapsed.
All payments due hereunder shall be converted into common stock, $0.001 par value per share (“Common Stock”) in accordance
with the terms hereof. All payments (share issuances) shall be made at such address as the Holder shall hereafter give to the
Company by written notice made in accordance with the provisions of this Note.


 


Whenever
any amount expressed to be due by the terms of this Note is due on any day which is not a business day, the same shall instead
be due on the next succeeding day which is a business day. As used in this Note, the term “business day” shall mean
any day other than a Saturday, Sunday or a day on which commercial banks in the City of London, England are authorized or required
by law to remain closed.


 


The
following terms shall apply to this Note:


 


	 	1.	CONVERSION
    RIGHTS



 


	 	a.	Conversion
    Right. The Company shall have the absolute right on the Maturity Date of this Note to pay the outstanding principal
    amount hereof together with accrued interest by issuing to the Holder shares of the Company’s Common Stock in lieu of
    paying cash to the Holder. The number of shares of Common Stock to be issued upon such conversion of this Note shall be determined
    by dividing the “Conversion Amount” (as defined below) by the “Conversion Price” (as defined and determined
    below). The term “Conversion Amount” means, the sum of (1) the principal amount of this Note plus (2) accrued
    and unpaid interest on such principal amount at the interest rate provided in this Note on the Maturity Date.


 


	 	b.	Conversion
    Price:


 


	 	1.	Calculation
    of Conversion Price. The conversion price (“Conversion Price”) shall be equal to closing price of Company’s
    Common Stock on the NASDAQ Over-the-Counter Bulletin Board two trading days prior to the maturity date (subject to equitable
    adjustments for stock splits and similar events). A “trading day” shall mean any day on which the Common Stock
    is tradable for any period on the stock exchange on which the Company’s Common Stock is traded or quoted. 
	 	 	 
	 	2.	Authorized
    Shares. The Company covenants that during the period the Note is outstanding, the Company will reserve from its authorized
    and unissued Common Stock enough shares (“Reserved Amount”) to provide for the issuance of Common Stock upon the
    full conversion of this Note. The Company represents that upon issuance, such shares will be duly and validly issued, fully
    paid and non-assessable. In addition, if the Company shall issue any securities or make any change to its capital structure
    which would change the number of shares of Common Stock into which the Notes shall be convertible at the then current Conversion
    Price, the Company shall at the same time make proper provision so that thereafter there shall be a sufficient number of shares
    of Common Stock authorized and reserved for conversion of the outstanding principal amount and accrued interest due under
    this Note. The Company (i) acknowledges that it has irrevocably instructed its transfer agent to issue certificates for the
    Common Stock issuable upon conversion of this Note, and (ii) agrees that its issuance of this Note shall constitute full authority
    to its officers and agents who are charged with the duty of executing stock certificates to execute and issue the necessary
    certificates for shares of Common Stock in accordance with the terms and conditions of this Note.
	 	 	 
	 	3.	If,
    at any time the Company does not maintain the Reserved Amount it will be considered an Event of Default under Section 3 of
    the Note.


 




    	 



     


    

 


	 	c.	Method
    of Conversion:


 


	 	1.	Surrender
    of Note upon Conversion. Notwithstanding anything to the contrary set forth herein, upon conversion of this Note in accordance
    with the terms hereof, the Holder shall be required to physically surrender this Note to the Company for cancellation. The
    Holder may not transfer this Note unless the Company consents thereto in writing and the Holder first physically surrenders
    this Note to the Company, whereupon the Company will forthwith issue and deliver upon the order of the Holder a new Note of
    like tenor, registered as the Holder (upon payment by the Holder of any applicable transfer taxes) may request, representing
    in the aggregate the remaining unpaid principal amount of this Note. 
	 	 	 
	 	2.	Delivery
    of Common Stock upon Conversion. Upon receipt by the Company from the Holder of an e-mail (or other reasonable means of
    communication) of a Notice of Conversion meeting the requirements for conversion as provided in this Section, the Company
    shall issue and deliver or cause to be issued and delivered to or upon the order of the Holder ́s certificates for the
    Common Stock issuable upon such conversion within three (3) business days after such receipt (the “Deadline”)
    (and, solely in the case of conversion of the entire unpaid principal amount hereof, surrender of this Note) in accordance
    with the terms hereof and the Purchase Agreement.


 


	 	d.	Concerning
    the Shares. The shares of Common Stock issuable upon conversion of this Note may not be sold or transferred
    unless (i) such shares are sold pursuant to an effective registration statement under the Act or (ii) the Company or its transfer
    agent shall have been furnished with an opinion of counsel (which opinion shall be in form, substance and scope customary
    for opinions of counsel in comparable transactions) to the effect that the shares to be sold or transferred may be sold or
    transferred pursuant to an exemption from such registration or (iii) such shares are sold or transferred pursuant to Rule
    144 under the Act (or a successor rule) (“Rule 144”). Until such time as the shares of Common Stock issuable upon
    conversion of this Note have been registered under the Act or otherwise may be sold pursuant to Rule 144 without any restriction
    as to the number of securities as of a particular date that can then be immediately sold, each certificate for shares of Common
    Stock issuable upon conversion of this Note that has not been so included in an effective registration statement or that has
    not been sold pursuant to an effective registration statement or an exemption that permits removal of the legend, shall bear
    a legend substantially in the following form, as appropriate:


 


“NEITHER
THE ISSUANCE AND SALE OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE
HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT
BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN
A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE
144A UNDER SAID ACT. NOTWITHSTANDING THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT
OR OTHER LOAN OR FINANCING ARRANGEMENT SECURED BY THE SECURITIES.”


 


The
legend set forth above shall be removed and the Company shall issue to the Holder a new certificate therefor free of any transfer
legend if (i) the Company or its transfer agent shall have received an opinion of counsel, in form, substance and scope customary
for opinions of counsel in comparable transactions, to the effect that a public sale or transfer of such Common Stock may be made
without registration under the Act, which opinion shall be accepted by the Company so that the sale or transfer is effected or
(ii) in the case of the Common Stock issuable upon conversion of this Note, such security is registered for sale by the Holder
under an effective registration statement filed under the Act or otherwise may be sold pursuant to Rule 144 without any restriction.


 




    	 



     


    

 


	 	e.	Effect
    of Certain Events.


 


	 	1.	Adjustment
    Due to Merger, Consolidation, etc. If, at any time when this Note is issued and outstanding and prior to conversion
    of all of the Notes, there shall be any merger, consolidation, exchange of shares, recapitalization, reorganization, or other
    similar event, as a result of which shares of Common Stock of the Company shall be changed into the same or a different number
    of shares of another class or classes of stock or securities of the Company or another entity, or in case of any sale or conveyance
    of all or substantially all of the assets of the Company other than in connection with a plan of complete liquidation of the
    Company, then the Holder of this Note shall thereafter have the right to receive upon conversion of this Note, upon the basis
    and upon the terms and conditions specified herein and in lieu of the shares of Common Stock immediately theretofore issuable
    upon conversion, such stock or securities which the Holder would have been entitled to receive in such transaction had this
    Note been converted in full immediately prior to such transaction (without regard to any limitations on conversion set forth
    herein), and in any such case appropriate provisions shall be made with respect to the rights and interests of the Holder
    of this Note to the end that the provisions hereof (including, without limitation, provisions for adjustment of the Conversion
    Price and of the number of shares issuable upon conversion of the Note) shall thereafter be applicable, as nearly as may be
    practicable in relation to any stock or securities thereafter deliverable upon the conversion hereof.


 


	 	2.	Adjustment
    Due to Distribution. If the Company shall declare or make any distribution of its assets (or rights to acquire its
    assets) to holder of Common Stock as a dividend, stock repurchase, by way of return of capital or otherwise (including any
    dividend or distribution to the Company’s shareholders in cash or shares (or rights to acquire shares) of capital stock
    of a subsidiary (i.e., a spin-off) (a “Distribution”), then the Holder of this Note shall be entitled, upon any
    conversion of this Note after the date of record for determining shareholders entitled to such Distribution, to receive the
    amount of such assets which would have been payable to the Holder with respect to the shares of Common Stock issuable upon
    such conversion had such Holder been the holder of such shares of Common Stock on the record date for the determination of
    shareholders entitled to such Distribution.


 


	 	3.	Notice
    of Adjustments. Upon the occurrence of each adjustment or readjustment of the Conversion Price as a result of the
    events described in this Section 1.6, the Company, at its expense, shall promptly compute such adjustment or readjustment
    and prepare and furnish to the Holder a certificate setting forth such adjustment or readjustment and showing in detail the
    facts upon which such adjustment or readjustment is based. The Company shall, upon the written request at any time of the
    Holder, furnish to such Holder a like certificate setting forth (i) such adjustment or readjustment, (ii) the Conversion Price
    at the time in effect and (iii) the number of shares of Common Stock and the amount, if any, of other securities or property
    which at the time would be received upon conversion of the Note.


 


	 	2.	CERTAIN
    COVENANTS


 


Sale
of Assets. So long as the Company shall have any obligation under this Note, the Company shall not, without the Holder ́s
written consent, sell, lease or otherwise dispose of any significant portion of its assets outside the ordinary course of business.
Any consent to the disposition of any assets may be conditioned on a specified use of the proceeds of disposition.


 


	 	3.	EVENTS
    OF DEFAULT


 


If
any of the following events of default (each, an “Event of Default”) shall occur:


 


	 	a.	Failure
    to Convert the Principal and/or Interest. The Company fails to covert the principal and/or accrued interest into shares
    of the Company ́s common stock when due on this Note at maturity.


 




    	 



     


    

 


	 	b.	Breach
    of Covenants. The Company breaches any material covenant or other material term, or condition contained in this Note
    and such breach continues for a period of thirty (30) days after written notice thereof to the Company from the Holder.


 


	 	c.	Breach
    of Representations and Warranties. Any representation or warranty of the Company made herein or in any agreement,
    statement or certificate given in writing pursuant hereto or in connection herewith, shall be false or misleading in any material
    respect when made and the breach of which has (or with the passage of time will have) a material adverse effect on the rights
    of the Holder with respect to this Note.


 


	 	d.	Receiver
    or Trustee. The Company or any subsidiary of the Company shall make an assignment for the benefit of creditors, or
    apply for or consent to the appointment of a receiver or trustee for it or for a substantial part of its property or business,
    or such a receiver or trustee shall otherwise be appointed.


 


	 	e.	Delisting
    of Common Stock. The Company shall fail to maintain the listing of the Common Stock on at least one of the OTC Pink
    Current Information, Over-the-Counter Bulletin Board or an equivalent replacement exchange, the Nasdaq National Market, the
    Nasdaq Small Cap Market, the New York Stock Exchange, or the American Stock Exchange.


 


	 	f.	Liquidation.
    Any dissolution, liquidation, or winding up of Company.


 


	 	4.	MISCELLANEOUS


 


	 	a.	Failure
    or Indulgence Not Waiver. No failure or delay on the part of the Holder in the exercise of any power, right or privilege
    hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege
    preclude other or further exercise thereof or of any other right, power or privileges. All rights and remedies existing hereunder
    are cumulative to, and not exclusive of, any rights or remedies otherwise available.


 


	 	b.	Notices.
    All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall
    be in writing and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered
    or certified, return receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid,
    or (iv) transmitted by hand delivery, telegram, or facsimile, addressed as set forth below or to such other address as such
    party shall have specified most recently by written notice. Any notice or other communication required or permitted to be
    given hereunder shall be deemed effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation generated
    by the transmitting facsimile machine, at the address or number designated below (if delivered on a business day during normal
    business hours where such notice is to be received), or the first business day following such delivery (if delivered other
    than on a business day during normal business hours where such notice is to be received) or (b) on the second business day
    following the date of mailing by express courier service, fully prepaid, addressed to such address, or upon actual receipt
    of such mailing, whichever shall first occur. The addresses for such communications shall be:


 


If
to the Company, to: 


 


Argentum
47, Inc.


34.
St. Augustine’s Gate,


Hedon
HU12 8EX,


United
Kingdom.


 


With
copy to:


 


David
E. Wise, Attorney


The
Colonnade,


9901
IH-10 West, Suite 800,


San
Antonio, Texas 78230


 




    	 



     


    

 


If
to the Holder:


 


Your
SICAV-SIF - Fortuna Global Growth


106
Route D`Arlon,


L-8210
Mamer,


Luxembourg.


 


	 	c.	Amendments.
    This Note and any provision hereof may only be amended by an instrument in writing signed by the Company and the Holder.
    The term “Note” and all reference thereto, as used throughout this instrument, shall mean this instrument as originally
    executed, or if later amended or supplemented, then as so amended or supplemented.


 


	 	d.	Assignability.
    This Note shall be binding upon the Company and its successors and/or its assignees and shall inure to be the benefit
    of the Holder and its successors and/or its assignees. Each transferee of this Note must be an “accredited investor”
    (as defined in Rule 501(a) of the 1933 Act).


 


	 	e.	Cost
    of Collection. If default is made in the payment of this Note, the Company shall pay the Holder hereof costs of collection,
    including reasonable attorneys’ fees.


 


	 	f.	Governing
    Law. This Note shall be governed by and construed in accordance with the laws of Luxembourg without regard to principles
    of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated by this
    Note shall be brought only in the courts of Luxembourg. The parties to this Note hereby irrevocably waive any objection to
    jurisdiction and venue of any action instituted hereunder and shall not assert any defence based on lack of jurisdiction or
    venue or based upon “forum non conveniens”. The Company and Holder waive trial by jury. The prevailing
    party shall be entitled to recover from the other party its reasonable attorney’s fees and costs. In the event that
    any provision of this Note or any other agreement delivered in connection herewith is invalid or unenforceable under any applicable
    statute or rule of law, then such provision shall be deemed inoperative to the extent that it may conflict therewith and shall
    be deemed modified to conform to such statute or rule of law. Any such provision which may prove invalid or unenforceable
    under any law shall not affect the validity or enforceability of any other provision of any agreement. Each party hereby irrevocably
    waives personal service of process and consents to process being served in any suit, action or proceeding in connection with
    this Agreement or any other Transaction Document by mailing a copy thereof via registered or certified mail or overnight delivery
    (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement and agrees that
    such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be
    deemed to limit in any way any right to serve process in any other manner permitted by law.


 


IN
WITNESS WHEREOF, Company has caused this Note to be signed in its name by its duly authorized officer this ____ day of ________________,
202_.


 


	 	ARGENTUM
    47, INC.
	 	 	 
	 	By:
    	
	 	 	Mr.
    __________________ – Director